Pharmafile Logo
Pharmafocus logo
Advanced Search

Sigilon

Showing 1 posts of 1 posts found.

Eli Lilly to acquire Sigilon Therapeutics

June 30, 2023
Business Services Chronic Diseases, Eli Lilly, Sigilon, acquisition

Eli Lilly and Sigilon Therapeutics have announced a definitive agreement for Lilly’s acquisition of Sigilon, a biopharmaceutical company focusing on …

News
The Gateway to Local Adoption Series

Latest content

Long-acting therapies set to reshape HIV treatment market

August 21, 2026

MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy

August 21, 2026

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026